PortalPublikationenNeue Aspekte in der Therapie von Schilddrüsenkarzinomen: Hig...

Neue Aspekte in der Therapie von Schilddrüsenkarzinomen: Highlights des ASCO-Kongresses 2016

Standard

Neue Aspekte in der Therapie von Schilddrüsenkarzinomen: Highlights des ASCO-Kongresses 2016. / Lörincz, B B; Simon, C; Möckelmann, N; Knecht, R.

in: HNO, Jahrgang 64, Nr. 10, 10.2016, S. 736-40.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Lörincz, BB, Simon, C, Möckelmann, N & Knecht, R 2016, 'Neue Aspekte in der Therapie von Schilddrüsenkarzinomen: Highlights des ASCO-Kongresses 2016', HNO, Jg. 64, Nr. 10, S. 736-40. https://doi.org/10.1007/s00106-016-0246-3

APA

Lörincz, B. B., Simon, C., Möckelmann, N., & Knecht, R. (2016). Neue Aspekte in der Therapie von Schilddrüsenkarzinomen: Highlights des ASCO-Kongresses 2016. HNO, 64(10), 736-40. https://doi.org/10.1007/s00106-016-0246-3

Vancouver

Lörincz BB, Simon C, Möckelmann N, Knecht R. Neue Aspekte in der Therapie von Schilddrüsenkarzinomen: Highlights des ASCO-Kongresses 2016. HNO. 2016 Okt;64(10):736-40. https://doi.org/10.1007/s00106-016-0246-3

Bibtex

@article{6eab8f40d8494f9c8f8bc7f266c68b64,
title = "Neue Aspekte in der Therapie von Schilddr{\"u}senkarzinomen: Highlights des ASCO-Kongresses 2016",
abstract = "The annual meeting of the American Society of Clinical Oncology (ASCO) took place at the beginning of June 2016 in Chicago. This year a total of 28 studies on the treatment of patients with thyroid cancer were presented, described in this review article according to the degree of cancer cell differentiation. The leading curative treatment modality is still surgery. In contrast, kinase inhibitors are being used increasingly within palliative concepts. The latest state of the art of thyroid cancer treatment, both surgical and medical, is summarized in this review.",
keywords = "English Abstract, Journal Article",
author = "L{\"o}rincz, {B B} and C Simon and N M{\"o}ckelmann and R Knecht",
year = "2016",
month = oct,
doi = "10.1007/s00106-016-0246-3",
language = "Deutsch",
volume = "64",
pages = "736--40",
journal = "HNO",
issn = "0017-6192",
publisher = "Springer",
number = "10",

}

RIS

TY - JOUR

T1 - Neue Aspekte in der Therapie von Schilddrüsenkarzinomen: Highlights des ASCO-Kongresses 2016

AU - Lörincz, B B

AU - Simon, C

AU - Möckelmann, N

AU - Knecht, R

PY - 2016/10

Y1 - 2016/10

N2 - The annual meeting of the American Society of Clinical Oncology (ASCO) took place at the beginning of June 2016 in Chicago. This year a total of 28 studies on the treatment of patients with thyroid cancer were presented, described in this review article according to the degree of cancer cell differentiation. The leading curative treatment modality is still surgery. In contrast, kinase inhibitors are being used increasingly within palliative concepts. The latest state of the art of thyroid cancer treatment, both surgical and medical, is summarized in this review.

AB - The annual meeting of the American Society of Clinical Oncology (ASCO) took place at the beginning of June 2016 in Chicago. This year a total of 28 studies on the treatment of patients with thyroid cancer were presented, described in this review article according to the degree of cancer cell differentiation. The leading curative treatment modality is still surgery. In contrast, kinase inhibitors are being used increasingly within palliative concepts. The latest state of the art of thyroid cancer treatment, both surgical and medical, is summarized in this review.

KW - English Abstract

KW - Journal Article

U2 - 10.1007/s00106-016-0246-3

DO - 10.1007/s00106-016-0246-3

M3 - SCORING: Zeitschriftenaufsatz

C2 - 27624902

VL - 64

SP - 736

EP - 740

JO - HNO

JF - HNO

SN - 0017-6192

IS - 10

ER -